AT13387 (Onalespib)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AT13387 (Onalespib), covering 2016-07-26 to 2022-09-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Study of AT13387 (Onalespib) in ALK+ ALCL, MCL, and BCL-6+ DLBCL [Phase 2]